Medical Coding Market Size, Share, and Trends 2024 to 2034

The global medical coding market size was USD 20.31 billion in 2023, estimated at USD 22.27 billion in 2024 and is anticipated to reach around USD 55.14 billion by 2034, expanding at a CAGR of 9.49% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 4299
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Coding Market 

5.1. COVID-19 Landscape: Medical Coding Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Coding Market, By Classification System

8.1. Medical Coding Market Revenue and Volume, by Classification System, 2024-2034

8.1.1 International Classification of Diseases (ICD)

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Healthcare Common Procedure Code System (HCPCS)

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Current Procedural Terminology (CPT)

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Medical Coding Market, By Component

9.1. Medical Coding Market Revenue and Volume, by Component, 2024-2034

9.1.1. In-House

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Outsourced

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Medical Coding Market, By End-user 

10.1. Medical Coding Market Revenue and Volume, by End-user, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Medical Coding Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Classification System (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Component (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

Chapter 12. Company Profiles

12.1. 3M Health Information Systems

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Aviacode Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Cerner Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Oracle Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Medical Information Technology Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Maxim Health Information Services

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Medical Record Associates LLC

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Cognizant Technology Solutions Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Verisk Analytics, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Optum, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client